First in Human Single Ascending Dose Study of MOR107
Clinical trial NCT03067363 · TERMINATED
Trial details
- NCT number
- NCT03067363
- Sponsor
- Alan Richardson
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-16
- Primary completion
- 2017-03-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.